Prehypertension: An Opportunity for a New Public Health Paradigm (Q37799421)

23 August 2017

title

Prehypertension: an opportunity for a new public health paradigm (English)

1 reference

23 August 2017

Prehypertension: An Opportunity for a New Public Health Paradigm (English)

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

31 July 2024

0 references

Brent M. Egan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20937441

31 July 2024

Daniel T. Lackland

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20937441

31 July 2024

Daniel W. Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20937441

31 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20937441

31 July 2024

publication date

1 November 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0733865110000883?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

https://api.elsevier.com/content/article/PII:S0733865110000883?httpAccept=text/plain

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

31 July 2024

1 reference

23 August 2017

volume

28

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

561-569

1 reference

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000.

31 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Borderline hypertension--a critical review

31 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Expanding the definition and classification of hypertension

31 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem

31 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Increased levels of tissue plasminogen activator antigen in essential hypertension. A population-based study in Sweden

31 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension

31 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients

31 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Endothelium-dependent vasodilation in normotensive subjects with a familial history of essential hypertension and in young subjects with borderline hypertension

31 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study

31 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

High-normal blood pressure is associated with poor cognitive performance.

31 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?

31 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Blood pressure and risk of type 2 diabetes mellitus in men and women from the general population: the Monitoring Trends and Determinants on Cardiovascular Diseases/Cooperative Health Research in the Region of Augsburg Cohort Study

31 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

High-normal blood pressure progression to hypertension in the Framingham Heart Study

31 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

From "prehypertension" to hypertension? Additional evidence.

31 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Feasibility of treating prehypertension with an angiotensin-receptor blocker

31 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study

31 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League

31 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Impact of high-normal blood pressure on the risk of cardiovascular disease

31 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Prehypertension and cardiovascular morbidity.

31 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease

31 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study

31 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification

31 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Prehypertension and cardiovascular disease risk in the Women's Health Initiative

31 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality

31 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study

31 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group

31 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men

31 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Smoking and diet intervention in healthy coronary high risk men. Methods and 5-year follow-up of risk factors in a randomized trial. The Oslo study

31 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

A decade of progress in the management of hypertension

31 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle

31 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

31 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

31 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men.

31 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

31 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.

31 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Trends in obesity and abdominal obesity among hypertensive and nonhypertensive adults in the United States

31 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Deteriorating dietary habits among adults with hypertension: DASH dietary accordance, NHANES 1988-1994 and 1999-2004.

31 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Origins and evolution of the Western diet: health implications for the 21st century

31 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Reduced physical activity and risk of chronic disease: the biology behind the consequences.

31 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Evidence for nutritional benefits in prolonging wellness

31 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients.

31 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure

31 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy

31 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change.

31 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

31 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome

31 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

31 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.CCL.2010.07.008

31 July 2024

Identifiers

1 reference

23 August 2017

1 reference